By Professor Susan Jane Connor

Journal articles

Connor SJ; Sechi A; Andrade M; Deuring JJ; Witcombe D, 2021, 'Ulcerative Colitis Narrative findings: Australian survey data comparing patient and physician disease management views', JGH Open, 5, pp. 1033 - 1040, http://dx.doi.org/10.1002/jgh3.12627

Karimi N; Kanazaki R; Lukin A; Moore AR; Williams AJ; Connor S, 2021, 'Clinical communication in inflammatory bowel disease: A systematic review of the study of clinician-patient dialogue to inform research and practice', BMJ Open, 11, http://dx.doi.org/10.1136/bmjopen-2021-051053

Wu Y; Wen A; Selvanderan SP; Xuan W; Andrews JM; Koo JH; Williams AJ; Ng W; Connor S, 2021, 'Management Decisions in Crohn's Disease Are Changed by Knowledge of Proactive and Reactive Testing of Antitumor Necrosis Factor Drug Levels', Crohn's and Colitis 360, 3, http://dx.doi.org/10.1093/crocol/otab042

Gu B; De Gregorio M; Pipicella JL; Vande Casteele N; Andrews JM; Begun J; Connell W; D'Souza B; Gholamrezaei A; Hart A; Liew D; Radford-Smith G; Rimola J; Sutherland T; Toong C; Woods R; Wu Y; Xuan W; Williams AJ; Ng W; Ding NS; Connor S, 2021, 'Prospective randomised controlled trial of adults with perianal fistulising Crohn's disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol', BMJ open, 11, http://dx.doi.org/10.1136/bmjopen-2020-043921

Kaazan P; Li T; Seow W; Bednarz J; Pipicella J; Ng W; Wiiliams AJ; Connor S; Andrews J, 2021, 'P232 Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease', Journal of Crohn's and Colitis, 15, pp. S281 - S281, http://dx.doi.org/10.1093/ecco-jcc/jjab076.358

De Gregorio M; Lee T; Krishnaprasad K; Amos G; An YK; Bastian-Jordan M; Begun J; Borok N; Brown DJM; Cheung W; Connor S; Gerstenmaier J; Gilbert LE; Gilmore R; Gu B; Kutaiba N; Lee A; Mahy G; Srinivasan A; Thin L; Thompson A; Welman CJ; Yong EX; De Cruz P; van Langenberg D; Sparrow co-lead senior author M; Ding NS, 2021, 'P399 Higher anti-tumour necrosis factor-alpha drug levels are associated with improved radiological outcomes in patients with perianal fistulising Crohn’s disease: A retrospective multi-centre study', Journal of Crohn's and Colitis, 15, pp. S408 - S409, http://dx.doi.org/10.1093/ecco-jcc/jjab076.523

Wu Y; Lin B; Thilakanathan C; Lehmann P; Xuan W; Mohsen W; Toong C; Williams AJ; Ng W; Connor S, 2021, 'Therapeutic drug monitoring in inflammatory bowel disease reduces unnecessary use of infliximab with substantial associated cost-savings', Internal Medicine Journal, 51, pp. 739 - 745, http://dx.doi.org/10.1111/imj.14644

Mohsen W; Williams AJ; Wark G; Sechi A; Koo JH; Xuan W; Bassan M; Ng W; Connor S, 2021, 'Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy?', World Journal of Gastroenterology, 27, pp. 1090 - 1100, http://dx.doi.org/10.3748/wjg.v27.i11.1090

Williams AJ; Paramsothy R; Wu N; Ghaly S; Leach S; Paramsothy S; Corte C; O'Brien C; Burke C; Wark G; Samocha-Bonet D; Lambert K; Ahlenstiel G; Wasinger V; Dutt S; Pavli P; Grimm M; Lemberg D; Connor S; Leong R; Hold G, 2021, 'Australia IBD Microbiome (AIM) Study: Protocol for a multicentre longitudinal prospective cohort study', BMJ Open, 11, http://dx.doi.org/10.1136/bmjopen-2020-042493

Kim AH; Girgis A; De Cruz P; Siegel CA; Karimi N; Ruban SO; Sechi AJ; Watson Ng WS; Andrews JM; Connor SJ, 2021, 'Development and feasibility of a web-based decision aid for patients with ulcerative colitis: Qualitative pilot study', Journal of Medical Internet Research, 23, http://dx.doi.org/10.2196/15946

Kaazan P; Li T; Seow W; Bednarz J; Pipicella JL; Krishnaprasad K; Ng W; Williams A-J; Connor SJ; Andrews JM, 2021, 'Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease', JGH OPEN, 5, pp. 1063 - 1070, http://dx.doi.org/10.1002/jgh3.12631

Connor S, 2021, 'Biologics in IBD', Pathology, 53, pp. S16 - S16, http://dx.doi.org/10.1016/j.pathol.2021.05.057

Connor S, 2021, 'Biologics in IBD', Pathology, 53, pp. S5 - S5, http://dx.doi.org/10.1016/j.pathol.2021.05.017

Prentice RE; Rentsch C; Al-Ani AH; Zhang E; Johnson D; Halliday J; Bryant R; Begun J; Ward MG; Lewindon PJ; Connor SJ; Ghaly S; Christensen B, 2021, 'SARS-CoV-2 vaccination in patients with inflammatory bowel disease.', GastroHep, 3, pp. 212 - 228, http://dx.doi.org/10.1002/ygh2.473

Sam MJ; Connor SJ; Ng WWS; Toong CML, 2020, 'Comparative Evaluation of 4 Commercially Available ELISA Kits for Measuring Adalimumab and Anti-adalimumab Antibodies', Therapeutic Drug Monitoring, 42, pp. 821 - 828, http://dx.doi.org/10.1097/FTD.0000000000000795

Krishnaprasad K; Walsh A; Begun J; Bell S; Carter D; Grafton R; Sechi A; Sewell K; McMahon A; Connor S; Radford-Smith G; Andrews JM, 2020, 'Crohn’s Colitis Care (CCCare): bespoke cloud-based clinical management software for inflammatory bowel disease', Scandinavian Journal of Gastroenterology, 55, pp. 1419 - 1426, http://dx.doi.org/10.1080/00365521.2020.1839960

Karimi N; Moore AR; Lukin A; Kanazaki R; Williams AJ; Connor S, 2020, 'Clinical communication in inflammatory bowel disease: A systematic literature review protocol', BMJ Open, 10, http://dx.doi.org/10.1136/bmjopen-2020-039503

Reddy Pulusu SS; Srinivasan A; Krishnaprasad K; Cheng D; Begun J; Keung C; Van Langenberg D; Thin L; Mogilevski T; de Cruz P; Radford-Smith G; Flanagan E; Bell S; Kashkooli S; Sparrow M; Ghaly S; Bampton P; Sawyer E; Connor S; Rizvi QUA; Andrews JM; Mahy G; Chivers P; Travis S; CraigLawrance I, 2020, 'Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford', World Journal of Gastroenterology, 26, pp. 4428 - 4441, http://dx.doi.org/10.3748/WJG.V26.I30.4428

Kim AH; Girgis A; Karimi N; Sechi AJ; Descallar J; Andrews JM; Siegel CA; Connor SJ, 2020, 'A web-based decision aid (myAID) to enhance quality of life, empowerment, decision making, and disease control for patients with ulcerative colitis: Protocol for a cluster randomized controlled trial', JMIR Research Protocols, 9, http://dx.doi.org/10.2196/15994

Aysha AA; Rentsch C; Prentice R; Johnson D; Bryant RV; Ward MG; Costello SP; Lewindon P; Ghaly S; Connor SJ; Begun J; Christensen B, 2020, 'Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty', Internal Medicine Journal, 50, pp. 798 - 804, http://dx.doi.org/10.1111/imj.14889

Gardiner FW; Bishop L; McMahon K; Nwose EU; Connor S; Begun J; Andrews JM, 2020, 'Aeromedical retrievals for gastrointestinal disorders in rural and remote Australia: the need for improved access to specialist advice', Internal Medicine Journal, 50, pp. 619 - 623, http://dx.doi.org/10.1111/imj.14822

Haifer C; Kelly CR; Paramsothy S; Andresen D; Papanicolas LE; McKew GL; Borody TJ; Kamm M; Costello SP; Andrews JM; Begun J; Chan HT; Connor S; Ghaly S; Johnson PDR; Lemberg DA; Paramsothy R; Redmond A; Sheorey H; Van Der Poorten D; Leong RW, 2020, 'Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice', Gut, 69, pp. 801 - 810, http://dx.doi.org/10.1136/gutjnl-2019-320260

Benson MJ; Abelev SV; Corte CJ; Connor SJ; McGregor IS, 2020, 'Attitudes and knowledge of australian gastroenterologists around the use of medicinal cannabis for inflammatory bowel disease', Crohn's and Colitis 360, 2, http://dx.doi.org/10.1093/crocol/otaa045

Benson MJ; Abelev SV; Connor SJ; Corte CJ; Martin LJ; Gold LK; Suraev AS; McGregor IS, 2020, 'Medicinal cannabis for inflammatory bowel disease: A survey of perspectives, experiences, and current use in australian patients', Crohn's and Colitis 360, 2, http://dx.doi.org/10.1093/crocol/otaa015

Julsgaard M; Hvas CL; Gearry RB; Gibson PR; Fallingborg J; Sparrow MP; Bibby BM; Connell WR; Brown SJ; Kamm MA; Lawrance IC; Vestergaard T; Svenningsen L; Baekdal M; Kammerlander H; Walsh A; Boysen T; Bampton P; Radford-Smith G; Kjeldsen J; Andrews JM; Subramaniam K; Moore GT; Jensen NM; Connor SJ; Wildt S; Wilson B; Ellard K; Christensen LA; Bell SJ, 2020, 'Anti-TNF Therapy in Pregnant Women with Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes', Inflammatory Bowel Diseases, 26, pp. 93 - 102, http://dx.doi.org/10.1093/ibd/izz110

Flanagan E; Gibson PR; Wright EK; Moore GT; Sparrow MP; Connell W; Kamm MA; Begun J; Christensen B; De Cruz P; Shelton E; Dowling D; Andrews JM; Brown SJ; Niewiadomski O; Ward MG; Rosella O; Rosella G; Kiburg KV; Ross AL; Bell SJ; PICCOLO Study Group , 2020, 'Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure.', Aliment Pharmacol Ther, 52, pp. 1551 - 1562, http://dx.doi.org/10.1111/apt.16102

Gu B; Venkatesh K; Williams A-J; Ng W; Corte C; Simon G; Xuan W; Paramsothy S; Connor SJ, 2020, 'Sa1891 HIGHER INFLIXIMAB AND ADALIMUMAB TROUGH LEVELS ARE ASSOCIATED WITH FISTULA HEALING IN PATIENTS WITH FISTULISING PERIANAL CROHN'S DISEASE', Gastroenterology, 158, http://dx.doi.org/10.1016/s0016-5085(20)31850-3

Little RD; Chu IE; Van Der Zanden EP; Flanagan E; Bell SJ; Gibson PR; Sparrow MP; Shelton E; Connor SJ; Roblin X; Ward MG, 2019, 'Comparison of Adalimumab Serum Drug Levels When Delivered by Pen Versus Syringe in Patients with Inflammatory Bowel Disease. An International, Multicentre Cohort Analysis', Journal of Crohn's and Colitis, 13, pp. 1527 - 1536, http://dx.doi.org/10.1093/ecco-jcc/jjz103

An YK; Prince D; Gardiner F; Neeman T; Linedale EC; Andrews JM; Connor S; Begun J, 2019, 'Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysis', Medical Journal of Australia, 211, pp. 461 - 467, http://dx.doi.org/10.5694/mja2.50384

Kim AH; Girgis A; De Cruz P; Siegel CA; Karimi N; Ruban SO; Sechi AJ; Ng WSW; Andrews JM; Connor SJ, 2019, 'Development and Feasibility of a Web-Based Decision Aid for Patients With Ulcerative Colitis: Qualitative Pilot Study (Preprint)', , http://dx.doi.org/10.2196/preprints.15946

Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO, 2019, 'Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis', Gastroenterology, 156, pp. 1440 - 1454.e2, http://dx.doi.org/10.1053/j.gastro.2018.12.001

Walker GJ; Harrison JW; Heap GA; Voskuil MD; Andersen V; Anderson CA; Ananthakrishnan AN; Barrett JC; Beaugerie L; Bewshea CM; Cole AT; Cummings FR; Daly MJ; Ellul P; Fedorak RN; Festen EAM; Florin TH; Gaya DR; Halfvarson J; Hart AL; Heerasing NM; Hendy P; Irving PM; Jones SE; Koskela J; Lindsay JO; Mansfield JC; McGovern D; Parkes M; Pollok RCG; Ramakrishnan S; Rampton DS; Rivas MA; Russell RK; Schultz M; Sebastian S; Seksik P; Singh A; So K; Sokol H; Subramaniam K; Todd A; Annese V; Weersma RK; Xavier R; Ward R; Weedon MN; Goodhand JR; Kennedy NA; Ahmad T; Holden AL; Andrews J; Auth M; Babu S; Bampton P; Banim P; Barnes T; Basude D; Beckly J; Bell A; Bell S; Bhandari P; Bloom S; Border D; Bredin F; Brookes MJ; Brown M; Calvert C; Campbell D; Chanchlani N; Chaudhary B; Chaudhary R; Chung-Faye G; Colleypriest B; Connor S; Cooney R; Cooper S; Creed TJ; Croft N; Cullen S; D'Amato M; D'Inca R; Dalal H; Daneshmend TK; Das D; Delaney M; DeSilva S; Dhar A; Dharmasiri S; Direkze N; Dunckley P; Elphick D; Everett SM; Feeney M; Fell J; Foley S; Franke A; Gavin D; Gee I, 2019, 'Association of Genetic Variants in NUDT15 with Thiopurine-Induced Myelosuppression in Patients with Inflammatory Bowel Disease', JAMA - Journal of the American Medical Association, 321, pp. 753 - 761, http://dx.doi.org/10.1001/jama.2019.0709

Armuzzi A; Kayhan C; Panaccione R; Watanabe K; Molander P; Rubin DT; Peyrin-Biroulet L; Melmed G; Connor S; Colombel J-F; Dubinsky M, 2019, 'P005 DELAY IN DIAGNOSIS OF ULCERATIVE COLITIS: RESULTS OF A GLOBAL ULCERATIVE COLITIS NARRATIVE SURVEY', Gastroenterology, 156, pp. S6 - S6, http://dx.doi.org/10.1053/j.gastro.2019.01.052

Schreiber S; Panaccione R; Kayhan C; Lopez-Sanroman A; Peyrin-Biroulet L; Armuzzi A; Dubinsky M; Melmed G; Rubin M; Connor S; Keefer L; Rubin DT, 2019, 'P023 PATIENT AND HEALTHCARE PROFESSIONAL VIEWS ON EMOTIONAL HEALTH AND INTIMACY IN ULCERATIVE COLITIS: RESULTS OF A GLOBAL ULCERATIVE COLITIS NARRATIVE SURVEY', Gastroenterology, 156, pp. S17 - S17, http://dx.doi.org/10.1053/j.gastro.2019.01.072

Liu F; Ma R; Tay CYA; Octavia S; Lan R; Chung HKL; Riordan SM; Grimm MC; Leong RW; Tanaka MM; Connor S; Zhang L, 2018, 'Genomic analysis of oral Campylobacter concisus strains identified a potential bacterial molecular marker associated with active Crohn's disease', Emerging Microbes and Infections, 7, pp. 1 - 14, http://dx.doi.org/10.1038/s41426-018-0065-6

Connor S, 2018, 'What can Australian Inflammatory Bowel Disease Association achieve in the next 3 to 5 years?', Journal of Gastroenterology and Hepatology (Australia), 33, pp. 35, http://dx.doi.org/10.1111/jgh.14437

Paramsothy S; Kamm M; Nielsen S; Deshpande N; Faith J; Clemente J; Paramsothy R; Walsh A; van den Bogaerde J; Samuel D; Leong R; Connor S; Ng W; Lin E; Wilkins M; Colombel J-F; Borody T; Mitchell H; Kaakoush N, 2018, 'OP019 In faecal microbiota transplantation (FMT) for ulcerative colitis, fusobacterium is associated with lack of remission, while metabolic shifts to starch degradation and short-chain fatty acid production are associated with remission (FOCUS study)', Journal of Crohn's and Colitis, 12, pp. S013 - S014, http://dx.doi.org/10.1093/ecco-jcc/jjx180.018

Krishnaprasad K; Walsh A; Begun J; Bell S; Carter D; Grafton R; Sechi A; Sewell K; McMahon A; Connor S; Radford-Smith G; Andrews J, 2018, 'P328 Crohn’s colitis care (CCCare): development and testing of a bespoke cloud-based clinical management system for inflammatory bowel disease (IBD)', Journal of Crohn's and Colitis, 12, pp. S266 - S268, http://dx.doi.org/10.1093/ecco-jcc/jjx180.455

Little R; Chu I; van der Zanden E; Flanagan E; Bell S; Sparrow M; Shelton E; Connor S; Roblin X; Ward M, 2018, 'P709 Is there a difference in adalimumab drug levels according to pen vs. syringe use: An international, multi-centre retrospective analysis', Journal of Crohn's and Colitis, 12, pp. S469 - S470, http://dx.doi.org/10.1093/ecco-jcc/jjx180.836

Paramsothy S; Kamm MA; Nielsen S; Deshpande N; Faith J; Clemente JC; Paramsothy R; Walsh A; van den Bogaerde J; Samuel D; Leong RW; Connor SJ; Ng WSW; Lin E; Wilkins M; Colombel JF; Borody TJ; Mitchell HM; Kaakoush NO, 2018, '130 - In Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis, Fusobacterium is Associated with Lack of Remission, while Metabolic Shifts to Starch Degradation and Short Chain Fatty Acid Production are Associated with Remission – Results from the Randomized Controlled Focus Study', Gastroenterology, 154, pp. S - 35, http://dx.doi.org/10.1016/s0016-5085(18)30588-2

Little RD; Chu IE; van der Zanden E; Flanagan E; Bell S; Sparrow M; Shelton E; Connor SJ; Roblin X; Ward MG, 2018, 'Mo1883 - Is There a Difference in Adalimumab Drug Levels According to Pen vs. Syringe use - An International, Multicenter Retrospective Analysis', Gastroenterology, 154, http://dx.doi.org/10.1016/s0016-5085(18)32847-6

Krishnaprasad K; Walsh A; Begun J; Bell S; Carter D; Grafton R; Sechi A; Sewell K; McMahon A; Connor SJ; Radford-Smith GL; Andrews JM, 2018, 'Tu1020 - Crohn's Colitis Care (CCcare) - Development and Testing of a Bespoke Cloud-Based Clinical Management System for Inflammatory Bowel Disease (IBD)', Gastroenterology, 154, pp. S - 892, http://dx.doi.org/10.1016/s0016-5085(18)33012-9

Lord A; Mortlock S; Montgomery G; Simms L; Krishnaprasad K; Hanigan K; Doecke JD; Gearry R; Lawrance I; Bampton PA; Andrews JM; Mahy G; Connor SJ; Sparrow M; Bell S; Walsh A; Radford-Smith GL, 2018, 'Tu1807 - Genetically Distinct Signatures of Mild and Severe Ulcerative Colitis', Gastroenterology, 154, pp. S - 1025, http://dx.doi.org/10.1016/s0016-5085(18)33433-4

Mitrev N; Vande Casteele N; Seow CH; Andrews JM; Connor SJ; Moore GT; Barclay M; Begun J; Bryant R; Chan W; Corte C; Ghaly S; Lemberg DA; Kariyawasam V; Lewindon P; Martin J; Mountifield R; Radford-Smith G; Slobodian P; Sparrow M; Toong C; van Langenberg D; Ward MG; Leong RW, 2017, 'Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases', Alimentary Pharmacology and Therapeutics, 46, pp. 1037 - 1053, http://dx.doi.org/10.1111/apt.14368

Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI, 2017, 'Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse', Gastrointestinal Endoscopy, 86, pp. 1070 - 1078, http://dx.doi.org/10.1016/j.gie.2017.09.011

Bye WA; Sparrow MP; Connor SJ; Andrews JM; Ellard K; Ng W; Hume G; Antoniades S; Walsh AJ, 2017, 'The need for better preventative strategies for inflammatory bowel disease patients at risk of herpes zoster virus', Internal Medicine Journal, 47, pp. 1263 - 1269, http://dx.doi.org/10.1111/imj.13488

Chen GB; Lee SH; Montgomery GW; Wray NR; Visscher PM; Gearry RB; Lawrance IC; Andrews JM; Bampton P; Mahy G; Bell S; Walsh A; Connor S; Sparrow M; Bowdler LM; Simms LA; Krishnaprasad K; Radford-Smith GL; Moser G, 2017, 'Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method', BMC Medical Genetics, 18, pp. 94, http://dx.doi.org/10.1186/s12881-017-0451-2

Lawrance IC; Baird A; Lightower D; Radford-Smith G; Andrews JM; Connor S, 2017, 'Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis', Clinical Gastroenterology and Hepatology, 15, pp. 1248 - 1255, http://dx.doi.org/10.1016/j.cgh.2017.02.027

Toong CML; Lee MWM; Connor S; Ng W, 2017, 'Response to: Comparison of infliximab drug measurement across three commercially available ELISA kits: author reply', Pathology, 49, pp. 334 - 335, http://dx.doi.org/10.1016/j.pathol.2017.01.005

Paramsothy S; Kamm MA; Kaakoush NO; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Xuan W; Lin E; Mitchell HM; Borody TJ, 2017, 'Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial', The Lancet, 389, pp. 1218 - 1228, http://dx.doi.org/10.1016/S0140-6736(17)30182-4

Back to profile page